This text is a result of machine translation.
And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Technology, Real Estate, Consumer DiscretionaryTech for Global, Globalization Footprints of the Established and the New
East China medicine "liraglutide" goes to sea
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Gilead Reached USD 455 Mn Contract with Everest for Asian Rights
The company said it would use the money to fund additional dealmaking activities, clinical development of Calliditas Therapeutics-partnered kidney disease drug Nefecon in several Asia countries and other pipeline assets.
Aug 16, 2022 05:47 PM
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
Bennu Biotherapeutics Bags Over CNY 100 Mn in Angel+ Financing Round
Biotech Bennu Biotherapeutics, focusing on the R&D and conversion of cutting-edge technologies in the cell therapy, will continue to contribute to global innovative cellular therapies for oncology and autoimmune diseases with the fresh proceeds.
Aug 15, 2022 05:19 PM
Acadia Alzheimer's drug SNDA application rejected by FDA advisory committee
Huashen Zhiyao completed nearly 500million yuan of a-round financing and went deep into AI new drug development
Huamei Haolian, a health management service enterprise, completed round a+ financing, and Jinshajiang venture capital led the investment
Mojia biology announced the completion of round B financing
A Quick Look at The Semiconductor Industry: 60 Players of Key Fields [2/2]
Aug 15, 2022 05:01 PM